Andrew Feinberg

Andrew Feinberg has extensive work experience in the technology and healthcare sectors. Andrew is currently the President & CEO of BostonGene, a company focused on personalized medicine and AI-based molecular and immune profiling for cancer patients. Andrew is also a Cofounder and Investor in the same company.

Prior to that, Feinberg served as the CEO & Chairman and President & CEO of Netcracker Technology, where they led the company in adapting to the rapidly evolving communications markets and driving digital transformation for service providers.

Before their role at Netcracker Technology, they worked as a Consultant at Bain & Company, where they gained valuable experience in the consulting field.

Andrew Feinberg has a Master of Business Administration (M.B.A.) degree from The Wharton School. Andrew also holds a Bachelor's Degree from Bentley University.